RNS
Announcement: USA Results
Baillie Gifford US Growth Trust plc ('USA')
Legal Entity Identifier:
213800UM1OUWXZPKE539
Regulated Information
Classification: Notice of
Results
Results for the year ended 31 May 2024
During the financial year to 31 May
2024, the Company's share price and net asset value ('NAV' after
deducting borrowings at fair value) returned 32.9% and 16.2%
respectively. This compares with a total return of 24.8% for the
S&P 500 Index* (in sterling terms).
- Turnover in the portfolio over the financial year was 14%
which is consistent with our five year plus time
horizon.
- As at
31 May 2024, we held 24 private company investments which
collectively compromised 34.1% of total assets.
- Oddity
listed during the period and one additional private company
investment was made: the digital retirement account manager
revolutionising the US market, Human Interest.
- Eight
listed holdings were added to the portfolio: Block, Guardant
Health, Inspire Medical Systems, Insulet, Meta Platforms, Samsara,
Sprout Social and YETI Holdings.
- Chegg,
Illumina, MarketAxess, Novocure, Redfin, Snap, Twilio, Warby Parker
and Zoom Video Communications were sold during the period. Convoy
ceased operations during the period and was written off.
- The US
remains a fertile hunting ground for growth investors. Its
companies are leading in new technological paradigms like AI, just
as they led previous innovation waves such as the internet and
mobile. Our aim is to identify the most exceptional amongst these
companies and hold them for the long term, thereby capturing the
unique upside that such companies offer.
Baillie Gifford US Growth Trust
seeks to invest predominantly in listed and unlisted US companies
which the Company believes have the potential to grow substantially
faster than the average company, and to hold onto them for long
periods of time, in order to produce long term capital growth. The
Company has total assets of £683.2 million (before deduction of
loans of £39.3 million) as at 31 May 2024.
You can find up to date performance
information about Baillie Gifford US Growth on the Company website
at bgusgrowthtrust.com‡.
Baillie Gifford US Growth Trust is
managed by Baillie Gifford & Co, the Edinburgh based fund
management group with approximately £217.8 billion under management
and advice in active equity and bond portfolios for clients in the
UK and throughout the world (as at 19 August 2024).
* Source:
LSEG and relevant underlying index providers. See disclaimer at the
end of this announcement. For a definition
of terms see Glossary of terms and alternative performance measures
at the end of this announcement.
‡ Neither
the contents of the Company website nor the contents of any website
accessible from hyperlinks on the Company website (or any other
website) is incorporated into, or forms part of, this
announcement.
Past performance is not a guide to future performance. The
value of an investment and any income from it is not guaranteed and
may go down as well as up and investors may not get back the amount
invested. This is because the share price is determined by the
changing conditions in the relevant stock markets in which the
Company invests and by the supply and demand for the Company's
shares.
22 August 2024
For further information please
contact:
Naomi Cherry, Baillie Gifford &
Co
Tel: 0131 275 2000
Jonathan Atkins, Four
Communications
Tel: 020 3920 0555 or 07872 495
396
The following is the results
announcement for the year to 31 May 2024 which was approved by the
Board on 21 August
2024.
Chair's statement
I am pleased to report an
improvement in performance during the financial year to 31 May
2024. The Company's share price and net asset value, calculated by
deducting borrowings at fair value, total returns were 32.9% and
16.2% respectively. This compares with a total return of 24.8% for
the S&P 500 Index* (in sterling terms).
Over the period from 23 March 2018
(launch date and first trade date), the Company's share price and
net asset value, calculated by deducting borrowings at fair value,
returned 91.4% and 121.2% respectively compared to a total return
of 152.0% for the S&P 500 Index* (in sterling
terms).
Further information about the
Company's portfolio performance is covered by our portfolio
managers, Gary Robinson and Kirsty Gibson, in their Managers'
review.
Share issuance and buy-backs
The Company's shares moved from a
discount of 22.4% at the start of the financial year to a discount
of 11.2% at 31 May 2024 as sentiment towards the Company's growth
investing style and the investment trust sector more generally
improved. During the financial year the Company deployed its
buy-back powers and 7,925,000 shares were bought back, representing
2.6% of the Company's issued share capital at the start of the
year. The Board recognises the importance of the Company's
liquidity policy and regularly discusses this topic at Board
meetings.
As at 31 May 2024, the Company had
authority, which was granted at the 2023 Annual General Meeting, to
issue a further 30,515,370 shares and to buy-back a further
45,742,539 shares. These authorities expire in September 2024. The
Company will be seeking to renew both the issuance and buyback
authorities at the forthcoming Annual General Meeting.
Gearing
The Company has two loan facilities
in place. The US$25 million five-year revolving credit facility
with ING Bank N.V., London Branch, which matured on 31 July 2023,
was refinanced with a US$25 million three-year revolving credit
facility from ING Bank N.V., London Branch on 26 July 2023. The
US$25 million three-year fixed rate facility with ING Bank N.V.,
London Branch matured on 23 October 2023 and was refinanced with a
US$25 million three-year revolving credit facility from The Royal
Bank of Scotland International Limited on 18 October 2023. The
facilities are available to be used to fund purchases of securities
as and when suitable opportunities arise. As at 31 May 2024, the
facilities had been drawn down in full (31 May 2023 - US$50
million). Net gearing fell from 6% to 5% over the course of the
year.
Earnings and dividend
The Company's priority is to
generate capital growth over the long term. The Company therefore
has no dividend target and will not seek to provide shareholders
with a particular level of dividend. The net revenue return per
share for the year to 31 May 2024 was a negative 2.07p (period to
31 May 2023, a negative 1.55p). As the revenue reserve is again
running at a deficit, the Board is recommending that no final
dividend be paid. Should the level of underlying income increase in
future years, the Board will seek to distribute the minimum
permissible to maintain investment trust status by way of a final
dividend.
Private company investments
As at the Company's year end, the
portfolio weighting in private company investments stood at 34.1%
of total assets, invested in 24 companies (2023 - 34.5% invested in
25 companies). There was one new purchase in the year, Human
Interest, and Oddity listed during the period (the Convoy holdings
were written off during the period subsequent to the company
ceasing operations). There is commentary on the new and existing
holdings in the Managers' review and review of investments below.
Your portfolio managers remain alert to further special and high
potential opportunities not widely accessible through public
markets.
Environmental, Social and
Governance (ESG) matters
The Company's Managers believe that
sustainability is inextricably linked to being a long-term
investor, and their thoughts on this topic are set out in more
detail in Baillie Gifford's stewardship principles below. The
Managers' pursuit of long-term growth opportunities typically
involves investment in entrepreneurial, disruptive and
technology-driven businesses. These companies are often
capital-light with a low carbon footprint.
Annual General Meeting
The Annual General Meeting of the
Company has been scheduled to be held at the offices of Herbert
Smith Freehills in London (Exchange House, Primrose Street, London,
EC2A 2EG) at 9.00am on Friday, 27 September 2024. All shareholders
are invited to attend, and the Board looks forward to welcoming
you. The meeting will be followed by a presentation from the
Managers. I encourage shareholders to submit their votes by proxy
before the applicable deadline ahead of the meeting and to submit
any questions for the Board or Managers in advance by email
to trustenquiries@bailliegifford.com
or by calling 0800 917 2112 (Baillie Gifford may
record your call).
Outlook
In our last report I allowed myself
to imagine that peaking interest rates might see valuations begin
to recover during 2024. Clearly the Board is delighted that we have
seen an improvement in our share price and a narrowing of our
discount over the intervening period. Perhaps more importantly
though, we continue to believe that the seismic changes in
technology that underpin many of the companies we are invested in
will continue and accelerate. We are at an inflexion point where
many verticals, from transportation to drug discovery to
communications and many others, are all ripe for disruption and we
firmly believe that the portfolio of businesses we own includes
many that will deliver outsize returns to long-term
investors.
Tom Burnet
Chairman
21 August 2024
* Source: LSEG and relevant
underlying index providers. See disclaimer at the end of this
announcement.
For a definition of terms see
Glossary of terms and alternative performance measures at the end
of this announcement.
Past performance is not a guide to
future performance.
Managers' review
In recent years, we have observed a
marked shift in emphasis among the companies in your portfolio.
There has been a pivot from prioritising growth alone to embracing
a more balanced approach that incorporates both growth and
profitability. In our previous interim report, we characterised
2022 as the 'year of reorientation' and 2023 as the 'year of
execution'. We are now witnessing the tangible benefits of this
strategic shift, as evidenced by the improved financial metrics
across your portfolio companies.
As of the end of March, 67% of the
portfolio was generating positive cash flow or positive earnings
per share ('EPS'), a notable increase from 48% in March 2023.
Crucially, growth has remained robust during this period of
improving profitability. The median revenue growth rate exceeded
18% over the year to March 2024, significantly outpacing the
S&P 500 Index. This dual achievement - maintaining strong
growth while enhancing profitability - is a testament to the
quality and adaptability of our chosen companies.
It is our view that many of your
holdings are emerging from the challenging post-Covid period in a
stronger position than when they entered it. These businesses have
not only addressed cost bases that had become inflated during the
pandemic but have also evolved their strategies, organisational
structures and processes. Companies that were buffeted by
pandemic-induced demand fluctuations have become leaner and more
agile, positioning themselves for higher profitability.
We see parallels between the current
situation and the period following the Global Financial Crisis.
Then, as now, many businesses faced unexpectedly weak demand, with
cyclical companies in the consumer discretionary and industrial
sectors particularly affected. However, we observed that the most
adaptable of these businesses emerged from that period stronger.
For instance, the multi-industrial business United Technologies
Group, which we held in our American Fund, achieved higher margins
in 2011 than in 2008, despite sales not having fully recovered. The
market underestimated this recovery, leading to strong share
performance.
A similar pattern is now unfolding
with internet-focused companies. Consider Shopify, the ecommerce
tools platform. Its free cash flow margin turned negative
post-Covid as lockdown-driven demand waned. However, following a
period of reorientation, margins have recovered to prior peak
levels and could potentially surpass them this year.
What drove Shopify to pursue such a
rapid turnaround? While there was some pressure to cut costs given
the shift in stock market sentiment, the company was motivated by a
more pressing concern. Chief executive Tobi Lütke recognised that
artificial intelligence ('AI') would be key to Shopify's future,
and he wanted to ensure the company was well-positioned to
capitalise on this opportunity. This required Shopify to become
leaner to move faster. Lütke insightfully noted that companies
often become sluggish not due to their size, but because of an
accumulation of 'side quests' - projects adjacent to the main
mission that don't directly serve it. While these may be manageable
during stable economic times, they can hinder agility when the
market landscape shifts.
In response, Shopify streamlined its
operations, divesting its logistics business to focus on AI. The
company also eliminated unnecessary meetings and cut bureaucracy,
resulting in a one-third increase in engineer productivity.
Customer service efficiency has also improved, with AI already
assisting in over half of customer service inquiries in the January
- March quarter. Shopify is optimistic that AI will help contain
costs while maintaining robust top-line growth. The newly
streamlined Shopify is emerging better positioned to exploit the
product and cost opportunities afforded by generative
AI.
The launch of ChatGPT at the end of
2022 brought AI into the spotlight, and we believe this attention
is warranted. Indeed, recent advancements in AI represent some of
the most important technological developments in a century. The
internet and mobile drove near universal access to computing power.
AI is rendering computers intelligent. It is outperforming humans
in certain tasks and is improving at a remarkable rate. It has the
potential to make large swathes of the economy more
efficient.
Our decision to reinvest in Meta
(previously Facebook) last year was partly driven by our view that
the company is uniquely placed to leverage AI. AI requires
substantial financial resources and data, both of which Meta
possesses in abundance. The company also boasts a strong
engineering culture and appears well-positioned to attract top
talent.
We see numerous parallels between
Shopify's strategic shift and Meta's 'year of efficiency'. Both
companies, compelled by necessity, streamlined their teams to
address the complexities bred from growth and to position
themselves for the new AI paradigm. Mark Zuckerberg optimised Meta
by trimming managerial layers, thus accelerating decision-making.
Like Shopify, he made the company leaner by cancelling lower
priority projects - the aforementioned 'side quests'. Zuckerberg
shares Lütke's view that side quests can slow a company down. For
instance, side quests require IT and HR support and, as these
functions grow, they can become less responsive to the main
mission. A leaner organisation, perhaps counterintuitively, often
executes faster.
AI is already beginning to impact
Meta's business. It was Meta's use of AI that enabled it to
successfully navigate Apple's ad-targeting rule changes a few years
ago. Meta is also using AI to refine its content recommendation
algorithm and has already seen improvements in user engagement as a
result.
Investments in AI are not
inexpensive. Both Meta and Amazon have revised their capital
expenditure budgets upward due to their AI spending plans. However,
this expenditure remains manageable in the context of their
prodigious cash flows. Indeed, Amazon's margins are on an upward
trend and, like Shopify's, are poised to exceed their prior peak
levels in the coming years.
NVIDIA, another holding in your
portfolio, has been a key beneficiary of this AI spending boom. Its
revenues grew by a remarkable 125% last year, and the shares
responded accordingly. We reduced our position earlier this year to
reflect the change in risk-reward profile.
As mentioned, we believe Shopify and
Meta have emerged from their periods of reorientation stronger and
better positioned for the future. Block has undergone a similar
transformation over the past year, which was one of the key
motivations for our recent investment. Block, which owns merchant
software provider Square and financial app Cash App, has always
been an exceptional product company. However, it historically
lacked financial discipline, and this lack of focus had begun to
impact its pace of innovation. This appears to be changing. Founder
Jack Dorsey is now managing the business to stringent targets that
balance both growth and profitability. Employee numbers have been
capped, and he has restructured the company to refocus on its core
mission. As a result, Block is now more agile and seems poised to
become significantly more profitable.
One feature common to Shopify, Meta
and Block, and indeed many of your other holdings, is the presence
of a founder-leader. It has long been our contention that
founder-led businesses are more adaptable than average. This is
partly because founders wield what Ben Horowitz calls 'moral
authority' - the credibility necessary to make substantial
strategic changes. The rapid transformations we have witnessed at
Shopify, Meta and Block in response to changing market conditions
are rare in non-founder-led businesses.
Portfolio changes
While AI has dominated recent
headlines, it is not the only disruptive force to have emerged in
recent years. In the healthcare sector, a new class of medicines
called GLP-1s has created a stir due to their ability to induce
weight loss. While we do not have direct exposure to manufacturers
of these drugs, the excitement surrounding GLP-1s indirectly led to
the purchase of two new healthcare holdings: Insulet, which
produces pumps for treating diabetes, and Inspire Medical Systems,
which manufactures surgical implants for sleep apnoea. Both stocks
experienced sell-offs due to fears that GLP-1s would shrink their
addressable markets. While diabetes and sleep apnoea are linked to
obesity, making this concern understandable, we believe that the
patient cohorts from which Insulet and Inspire derive most of their
revenues are unlikely to be significantly impacted by GLP-1s. We
had been following both businesses for some time and used this
weakness as an opportunity to initiate positions.
Other notable new holdings in the
period include: Guardant Health, a provider of molecular diagnostic
tests for cancer; YETI, a consumer branded goods company renowned
for its durable coolers and drinks containers; Sprout Social, a
social media management platform; and Samsara, a provider of
telematics and safety technology for the trucking
industry.
We also made several complete sales
during this period. We parted ways with communications software
provider Twilio, which had been underperforming for some time. The
catalyst for this sale was the departure of its founder, Jeff
Lawson. We also divested our position in videoconferencing software
company Zoom, which was struggling to grow amidst fierce
competition from Microsoft's Teams. Other complete sales included
Snap, Chegg, Illumina, MarketAxess, Novocure, Redfin and Warby
Parker.
While this may seem like a
substantial list of changes, it's important to note that our
portfolio turnover remains low at 14%, consistent with our five to
ten-year holding period. This underscores our commitment to
long-term investing and our conviction in the companies we
hold.
On the unlisted front, we made one
additional investment during the year: Human Interest, which helps
small and medium-sized businesses offer retirement plans to their
employees.
The IPO market is beginning to show
signs of life, although volumes remain well below pre-pandemic
levels. As mentioned in our interim report, one of your holdings,
online cosmetics company Oddity, went public during the year. We
anticipate that more of your private businesses will transition to
public markets in the coming years.
At the end of the reporting period,
the Company held 24 private companies, which in aggregate comprised
34.1% of total assets. The allocation to private companies is
concentrated, with the top five private companies comprising over
half of the allocation, and the top ten comprising over
three-quarters. We have provided a summary of the operational
progress of the top ten private companies on pages 38 to 40 of the
Annual Report and Financial Statements.
Outlook
The US remains a fertile hunting
ground for growth investors. Its companies are leading in new
technological paradigms like AI, just as they led previous
innovation waves such as the internet and mobile. Our aim is to
identify the most exceptional amongst these companies and hold them
for the long term, thereby capturing the unique upside that such
companies offer. In our experience, one of the key features that
unites such firms is adaptability. To endure and thrive over the
long term, businesses must be able to respond effectively to
changing market circumstances and technological paradigms. The
transformations we have witnessed at holdings including Shopify,
Meta, Block and, indeed, NVIDIA over the past few years are
extremely encouraging in this context. They have demonstrated their
adaptability and are now better positioned for the
future.
The next cohort of generationally
important companies will share this ability to adapt, innovate, and
position themselves for a rapidly evolving future. It is our
conviction that many such companies are present in your portfolio,
across both your public and private holdings.
Markets have been volatile lately,
reflecting uncertainty about the future. We believe our investee
companies have the qualities necessary to navigate through this
uncertainty. The best companies create
opportunities for themselves, even in challenging environments. We
believe this feature is structurally underappreciated by markets
and exploitable by patient investors.
As we look ahead, we remain excited
about the prospects for your portfolio and confident in our ability
to continue identifying and investing in the companies that will
shape the future of the global economy.
US Equity Growth Team
Baillie Gifford & Co
21 August 2024
Purpose and investment principles
Baillie Gifford US Growth aims to
deliver above average long-term returns for shareholders by keeping
fees and costs low and harnessing the long-term growth potential of
companies.
Our
purpose
Baillie Gifford US Growth aims to
find, own and support the most exceptional public and private
growth companies in America.
We believe that our investment
approach of long termism, embracing asymmetry, and global
perspective gives us an advantage in uncovering exceptional growth
companies. Our opportunity set is wide given the Company's
structure means we can invest in exceptional growth companies
regardless of their listed status.
Exceptional growth companies address
huge market opportunities at an early stage, possess a sustainable
competitive edge and enjoy powerful and effective cultures that
enable them to realise their long-term potential. We believe such
companies contribute to productive innovation in society, and over
the full course of time, these companies will develop deep
competitive moats and generate abnormal profits and unusually high
shareholder returns.
We endeavour to generate returns for
our clients by helping in the creation and improvement of such
useful enterprises. If we are successful in identifying these
companies, we believe that we can multiply our shareholders' wealth
over the long term.
Our
investment principles
Managing shareholders' money is a
huge privilege and not one we take lightly. It is a relationship,
not a transaction. Relationships can only be built on a foundation
of trust and understanding. With this in mind, we seek to lay out
the fundamental principles by which we will manage your money and
the framework for how we make decisions so that you, our
shareholders, can decide whether it aligns with your investment
philosophy.
• We believe the fundamental measure
of our success will be the value we create for our shareholders
over the long term. It is only over periods of five years or more
that the characteristics we look for in businesses become apparent.
Our turnover has been low, consistent with our time horizon. We ask
that our shareholders measure our performance over similar
periods.
• Short-term volatility is an
inevitable feature of the market, and we will not manage the
portfolio to reduce volatility at the expense of long-term gain.
Many managers are risk-averse and fear loss more than they value
gain. Therefore, they accept smaller, more predictable risks rather
than the larger and less predictable ones. We believe that this is
harmful to long-term returns, and we will not shy away from making
investments that are perceived to be risky if we believe that the
potential payoffs are worthwhile. This means that our performance
may be lumpy over the short term.
• We believe, and academic work has
shown, that long-term equity returns are dominated by a small
handful of exceptional growth companies that deliver outsized
returns. Most stocks do not matter for long-term equity returns,
and investors will be poorly served by owning them. In our search
for exceptional growth companies, we will make mistakes. But the
asymmetry inherent in equity markets, where we can make far more in
a company if we are right than lose if we are wrong, tells us that
the costliest of mistakes is excessive risk aversion.
• We do not believe that the index
is the right starting point for portfolio construction. The index
allocates capital based on size. We believe that capital should be
allocated based on marginal return and the ability to grow at those
rates of return. Big companies are not immune to disruption. We do
not manage the portfolio to an active share target, but we expect
the active share of the Company to be high.
• We are largely indifferent to a
company's private or public status. We will conduct diligent
analysis and allocate capital to where the highest returns are
likely to be.
• We believe our duty is to maximise
the long-term wealth of our shareholders, and that placing emphasis
on short-term performance serves our shareholders
poorly.
• We will endeavour to operate in
the most efficient, honest and economical way possible. That means
keeping our ongoing costs including management fees low. We
recognise that even modest amounts, when allowed to compound over
long periods of time, add up to staggering sums, and we do not wish
to dilute the compounding of returns with the compounding of
costs.
With this foundation, we aim to
build Baillie Gifford US Growth Trust into a world-class savings
vehicle. We are grateful that you have joined us on this journey,
and we look forward to a long and hopefully prosperous relationship
with you.
Baillie Gifford's stewardship principles
Baillie Gifford's overarching ethos
is that we are 'Actual' investors. That means we seek to invest for
the long term. Our role as an engaged owner is core to our mission
to be effective stewards for our clients. As an active manager, we
invest in companies at different stages of their evolution across
many industries and geographies, and focus on their unique
circumstances and opportunities. Our approach favours a small
number of simple principles rather than overly prescriptive
policies. This helps shape our interactions with holdings and
ensures our investment teams have the freedom and retain the
responsibility to act in clients' best interests.
Long-term value creation
We believe that companies that are
run for the long term are more likely to be better investments over
our clients' time horizons. We encourage our holdings to be
ambitious, focusing on long-term value creation and capital
deployment for growth. We know events will not always run according
to plan. In these instances we expect management to act
deliberately and to provide appropriate transparency. We think
helping management to resist short-term demands from shareholders
often protects returns. We regard it as our responsibility to
encourage holdings away from destructive financial engineering
towards activities that create genuine value over the long run. Our
value will often be in supporting management when others
don't.
Alignment in vision and practice
Alignment is at the heart of our
stewardship approach. We seek the fair and equitable treatment of
all shareholders alongside the interests of management. While
assessing alignment with management often comes down to intangible
factors and an understanding built over time, we look for clear
evidence of alignment in everything from capital allocation
decisions in moments of stress to the details of executive
remuneration plans and committed share ownership. We expect
companies to deepen alignment with us, rather than weaken it, where
the opportunity presents itself.
Governance fit for purpose
Corporate governance is a
combination of structures and behaviours; a careful balance between
systems, processes and people. Good governance is the essential
foundation for long-term company success. We firmly believe that
there is no single governance model that delivers the best
long-term outcomes. We therefore strive to push back against
one-dimensional global governance principles in favour of a deep
understanding of each company we invest in. We look, very simply,
for structures, people and processes which we think can maximise
the likelihood of long-term success. We expect to trust the boards
and management teams of the companies we select, but demand
accountability if that trust is broken.
Sustainable business practices
A company's ability to grow and
generate value for our clients relies on a network of
interdependencies between the company and the economy, society and
environment in which it operates. We expect holdings to consider
how their actions impact and rely on these relationships. We
believe long-term success depends on maintaining a social licence
to operate and look for holdings to work within the spirit and not
just the letter of the laws and regulations that govern them.
Material factors should be addressed at the board level as
appropriate.
Review of investments
A review of the Company's ten
largest investments and additions to the private company
investments as at 31 May 2024.
Top ten holdings
Space Exploration Technologies U
7.6% of total assets*
An aerospace and space
transportation company that manufactures advanced rockets, like the
Falcon 9, and satellites, like Starlink, which provides global
broadband services. We are excited by its pursuit of reduced launch
costs, thus opening avenues for growth, such as tourism and
transportation. A clear segment leader, it looks positioned to
capture an attractive share of the growing space industry, while
Starlink may become the first globally relevant utility.
NVIDIA
6.5% of total assets*
NVIDIA designs and manufactures
graphics processing units for the gaming and professional markets.
They are highly specialised semiconductor chips that can be used
for a range of applications, from gaming to artificial intelligence
('AI'). After years of investment into both hardware and software,
NVIDIA is well positioned to benefit from the rise of generative
AI, as its chips form the infrastructure layer to power large
language models. NVIDIA is using its scale to further reinvest in
its opportunity; designing new hardware to make data centres more
powerful and energy efficient, while building software to help
companies adopt AI more quickly.
Amazon
5.2% of total assets*
In retail, Amazon competes on price,
selection and convenience and is improving all three as it gets
bigger. Amazon's AWS (Amazon Web Services) division is in a clear
position of leadership in what could turn out to be one of the
largest and most important market shifts of our time. Both
opportunities are outputs of what is perhaps most distinctive of
all about Amazon - its culture. The company is run with a uniquely
long-term perspective. It is willing to be bold and scale its
experiments (and failures) as it grows. These cultural distinctions
allow Amazon to possess the rare and attractive combination of
scale and immaturity.
The
Trade Desk
5.0% of total assets*
The advertising industry is
undergoing a wholesale shift. In the past advertising was bought
and sold in bundles. In the digital world, advertising can be
transacted on a one-to-one basis, targeting only the audiences that
are relevant. The Trade Desk provides the technology that enables
this targeted buying of advertising through real-time auctions.
This is known as programmatic advertising. Programmatic advertising
is growing rapidly, supported by higher efficacy and a tangible
demonstration of return on investment. We believe that The Trade
Desk will emerge as the leading buying platform for the independent
internet.
Stripe U
4.6% of total assets*
Stripe is a payments technology
company. Founded in 2010 by Irish brothers Patrick and John
Collison, the company is in the process of developing a platform
for sending money seamlessly and compliantly between any two
internet-connected nodes in the world. The company processes
massive volumes of payments from a broad customer base, ranging
from US start-ups to global giants. Stripe's long-term ambition is
to make entrepreneurship easier and thus significantly increase the
amount of business conducted online.
Meta Platforms
3.7% of total assets*
Meta Platforms is the owner of
Facebook, WhatsApp and Instagram. We think that AI could be a
significant growth driver. In the nearer term, it should facilitate
revenue growth as AI systems allow adverts to be targeted more
effectively despite Apple's privacy restrictions. Facebook may be
unique in having the engineering resources to take advantage of
this opportunity. The company addressed its cost base last year,
leaving it well-placed to take on this challenge. In the longer
term, AI should facilitate the monetisation of WhatsApp, a platform
that enjoys widespread usage but has struggled to find a revenue
model.
Moderna
3.4% of total assets*
Moderna is a leader in the field of
mRNA therapeutics. mRNA is a foundational technology that
theoretically has the potential to induce the production of just
about any protein - human or non-human - inside our cells. This
versatility opens up a wide range of therapeutic opportunities for
mRNA. mRNA is in a sense digital, and is therefore programmable. In
moving from one drug to the next, the delivery mechanism and
building blocks remain the same. The only thing that changes is the
code. Because of this, Moderna's mRNA platform ought to be more
scalable than past drug development approaches. Moderna may have
more in common with a software company than a biotech
business.
Netflix
3.4% of total assets*
Netflix has the potential to become
the first truly global content and distribution media brand. Its
base of more than 230 million subscribers allows it to invest in
building a strong customer proposition through its library of
exclusive and desirable content. This in turn attracts more
subscribers, creating a powerful flywheel that distances itself
from other likely competitors. The shift from linear TV to
on-demand streaming is still in the early stages, and Netflix is a
prime beneficiary.
Shopify
3.1% of total assets*
Shopify provides software tools
which allow merchants to easily set up and manage their businesses
across an increasingly complex and fragmented retail landscape.
Shopify's software helps to make merchants more efficient by
automating large swathes of their operations (e.g. marketing,
inventory management, payments, order processing, shipping) thus
allowing them to focus on product market fit. The company maintains
a rapid pace of innovation and is run by an impressive founder who
has built a distinctive merchant focused culture.
Brex U
3.1% of total assets*
Brex is building an all-in-one
platform for businesses to manage their finances. It started by
offering a corporate card for venture-backed business. It has
expanded into larger businesses and is now offering a broader suite
of products including business accounts, expense management and
bill pay software. Existing options are expensive and do not work
well with one another. Brex is aiming to build a fully integrated
suite which will act as the financial operating system for growing
businesses. Its business model and approach have demonstrated
strong alignment with its customers, a rarity in this sector. This
customer focus, coupled with the strength of the founding team and
breadth of their ambition, leave Brex well placed to exploit this
large opportunity.
Private company new buy
Human Interest U
0.7% of total assets*
Human Interest is a digital
retirement account manager giving SME employers the ability to
offer employees 401(k) and IRA (individual retirement account)
plans. This is a massively underserved part of the market - 50% of
American households have no retirement accounts. The possibilities
of real-time payroll SaaS (software as a service) integrations
enable automated and therefore very low cost 401(k) administration.
Human Interest has become the clear leader in the space. It has: a
large end market; a rapidly growing product that has a plausible
regulatory tailwind; a business model that shows clear signs of
operating leverage; and a decent argument for business model
innovation against the incumbents.
U Denotes private
company investment.
*Total assets less current
liabilities, before deduction of borrowings. See Glossary of terms
and alternative performance measures at the end of this
announcement.
Portfolio executive summary
Key
contributors to and detractors from performance - year to 31 May
2024
Contributors
|
Contribution to absolute
performance
%*
|
Absolute
performance
%†
|
Detractors
|
Contribution to absolute
performance
%*
|
Absolute
performance
%†
|
NVIDIA
|
6.4
|
182.7
|
Convoy U
|
(1.3)
|
(100.0)
|
Space Exploration
Technologies U
|
2.0
|
32.2
|
Novocure
|
(1.0)
|
(80.0)
|
Amazon
|
1.9
|
42.4
|
Denali
Therapeutics
|
(0.4)
|
(40.2)
|
Netflix
|
1.6
|
58.0
|
Indigo
Agriculture U
|
(0.4)
|
(94.5)
|
DoorDash
|
1.4
|
64.1
|
Solugen U
|
(0.4)
|
(19.2)
|
* Contribution to absolute performance (in sterling terms) has
been calculated to illustrate how an individual stock has
contributed to the overall return. It is influenced by both share
price performance and the weighting of the stock in the portfolio,
taking account of any purchases or sales over the
period.
† Absolute performance (in sterling
terms) has been calculated on a total return basis over the period
1 June 2023 to 31 May 2024. For the definition of total return see
Glossary of terms and alternative performance measures at the end
of this announcement. Table ordered by contribution to
performance.
U Denotes private
company investment.
Source: Revolution.
Distribution of total assets* by sector 2024
|
Industry
|
2024
%
|
2023
%
|
1
|
Information technology
|
29.9
|
31.3
|
2
|
Consumer discretionary
|
19.0
|
18.8
|
3
|
Communication services
|
15.6
|
11.7
|
4
|
Industrials
|
12.5
|
16.2
|
5
|
Healthcare
|
12.1
|
13.7
|
6
|
Financials
|
6.2
|
3.9
|
7
|
Real estate
|
1.6
|
0.3
|
8
|
Materials
|
1.4
|
2.3
|
9
|
Consumer staples
|
1.0
|
1.3
|
10
|
Net liquid assets
|
0.7
|
0.5
|
Source: Baillie Gifford/LSEG and
relevant underlying index providers. See disclaimer at the end of
this announcement.
* For a
definition of terms see Glossary of terms and alternative
performance measures at the end of this announcement.
Baillie Gifford - valuing private companies
We hold our private company
investments at 'fair value' i.e. the price that would be paid in an
open- market transaction. Valuations are adjusted both during
regular valuation cycles and on an ad hoc basis in response to
'trigger events'. Our valuation process ensures that private
companies are valued in both a fair and timely manner.
The valuation process is overseen by
a valuations group at Baillie Gifford, which takes advice from an
independent third party (S&P Global). The valuations group is
independent from the investment team with all voting members being
from different operational areas of the firm, and the investment
managers only receive final notifications once they have been
applied.
We revalue
the private holdings on a three-month rolling cycle, with one third
of the holdings reassessed each month. During stable market
conditions, and assuming all else is equal, each investment would
be valued four times in a twelve-month period. For investment
trusts, the prices are also reviewed twice per year by the
respective investment trust boards and are subject to the scrutiny
of external auditors in the annual audit process.
Beyond the regular cycle, the
valuations team also monitors the portfolio for certain 'trigger
events'. These may include: changes in fundamentals; a takeover
approach; an intention to carry out an Initial Public Offering
('IPO'); company news which is identified by the valuation team or
by the portfolio managers; or meaningful changes to the valuation
of comparable public companies. Any ad hoc change to the fair
valuation of any holding is implemented swiftly and reflected in
the next published net asset value.
The valuations group also monitors
relevant market indices on a weekly basis and updates valuations in
a manner consistent with our external valuer's (S&P Global)
most recent valuation report where appropriate.
Periods of market volatility during
the year has meant that valuations continue to be reviewed much
more frequently, in some instances resulting in a further valuation
movement. The data below quantifies the revaluations carried out
during the year to 31 May 2024, but does not reflect the ongoing
monitoring of the private investment portfolio that has not
resulted in a change in valuation.
Baillie Gifford US Growth
Trust*
|
|
Instruments held
|
56
|
Number of revaluations
|
288
|
Percentage of portfolio valued up to
4 times
|
30.4%
|
Percentage of portfolio valued 5+
times
|
69.6%
|
*Data reflecting period 1 June 2023
to 31 May 2024 to align with the Company's reporting period
end.
Whilst pockets of heightened
volatility remain, the general improvement in market sentiment is
reflected in the private company valuations at 31 May 2024. The
average movement in company valuations and share prices across the
portfolio are shown below.
|
Average
movement
in company
valuation
|
Average
movement in share price
|
Baillie Gifford US Growth
Trust*
|
15.7%
|
22.2%
|
*Data reflecting period 1 June 2023
to 31 May 2024 to align with the Company's reporting period
end.
Private companies summary
Historical snapshot
Since our first investment in
private companies in 2018, Baillie Gifford US Growth has deployed
£242.5m of capital in this area.
Portfolio activity - year to 31 May 2024
£8.2m of new capital was deployed in
private companies during the year.
New buys
|
Follow on funding rounds
|
|
Human Interest
|
BillionToOne
|
Databricks
|
|
Honor Technology
|
|
Oddity listed during the period.
Subsequent to Convoy ceasing operations the holdings in it were
written off during the year (see note 9 of the Financial Statements
on page 100 of the Annual Report and Financial
Statements).
Concentration
At 31 May 2024 we held 24 private
companies which equated to 34.1% of total assets.
- Five
companies account for 57.3% of the private company
exposure.
- Ten
companies account for 78.1% of the private company
exposure.
|
Private exposure
|
31
May 2024
%
|
31
May 2023
%
|
1
|
Space Exploration
Technologies
|
7.6
|
6.5
|
2
|
Stripe
|
4.6
|
4.2
|
3
|
Brex
|
3.1
|
2.6
|
4
|
Zipline
|
2.1
|
2.3
|
5
|
Faire Wholesale
|
1.9
|
2.2
|
6
|
Other
|
14.8
|
16.7
|
Size
Our private company exposure tends
to be weighted to the upper end of the maturity curve, focused on
late stage private companies who are scaling up and becoming
profitable.
Cap
|
Total equity value (USD)
|
% of total
assets*
|
Number of holdings
|
Micro
|
<300m
|
0.5
|
3
|
Small
|
300m-2bn
|
5.2
|
7
|
Medium
|
2bn-10bn
|
10.3
|
9
|
Large
|
>10bn
|
18.1
|
5
|
|
|
34.1
|
24
|
*Total assets less current
liabilities, before deduction of borrowings. See Glossary of terms
and alternative performance measures at the end of this
announcement.
List of investments
as
at 31 May 2024
Name
|
Business
|
2024
Value
£'000
|
% of total
assets*
|
2023
Value
£'000
|
Space Exploration Technologies
Series J Preferred U
|
Rocket and spacecraft
company
|
26,502
|
3.9
|
20,041
|
Space Exploration Technologies
Series N Preferred U
|
Rocket and spacecraft
company
|
15,214
|
2.2
|
11,505
|
Space Exploration Technologies
Series K Preferred U
|
Rocket and spacecraft
company
|
6,040
|
0.9
|
4,568
|
Space Exploration Technologies
Class A Common U
|
Rocket and spacecraft
company
|
3,139
|
0.5
|
2,374
|
Space Exploration Technologies
Class C Common U
|
Rocket and spacecraft
company
|
969
|
0.1
|
732
|
|
|
51,864
|
7.6
|
39,220
|
NVIDIA
|
Graphics chips
|
44,715
|
6.5
|
24,334
|
Amazon
|
Online retailer and cloud computing
provider
|
35,710
|
5.2
|
22,361
|
The Trade Desk
|
Advertising technology
company
|
34,288
|
5.0
|
32,448
|
Stripe Series G Preferred
U
|
Online payment platform
|
13,984
|
2.0
|
11,110
|
Stripe Series I Preferred
U
|
Online payment platform
|
13,625
|
2.0
|
10,860
|
Stripe Class B Common
U
|
Online payment platform
|
2,871
|
0.4
|
2,281
|
Stripe Series H Preferred
U
|
Online payment platform
|
1,527
|
0.2
|
1,430
|
|
|
32,007
|
4.6
|
25,681
|
Meta Platforms
|
Social networking
websites
|
25,369
|
3.7
|
-
|
Moderna
|
Therapeutic messenger RNA
|
23,506
|
3.4
|
21,025
|
Netflix
|
Subscription service for TV shows
and movies
|
23,441
|
3.4
|
17,247
|
Shopify
|
Cloud-based commerce platform
provider
|
21,747
|
3.1
|
33,135
|
Brex Class B Common
U
|
Corporate credit cards for
start-ups
|
10,648
|
1.6
|
8,050
|
Brex Series D Preferred
U
|
Corporate credit cards for
start-ups
|
10,018
|
1.5
|
7,574
|
|
|
20,666
|
3.1
|
15,624
|
DoorDash
|
Online local delivery
|
17,845
|
2.6
|
11,482
|
Tesla
|
Electric cars, autonomous driving
and solar energy
|
17,239
|
2.4
|
24,967
|
Zipline International Series
C
Preferred U
|
Drone-based medical
delivery
|
8,910
|
1.3
|
8,771
|
Zipline International Series
E
Preferred U
|
Drone-based medical
delivery
|
5,049
|
0.7
|
4,970
|
Zipline International Series
F
Preferred U
|
Drone-based medical
delivery
|
820
|
0.1
|
807
|
|
|
14,779
|
2.1
|
14,548
|
Cloudflare
|
Cloud-based provider of network
services
|
13,357
|
1.9
|
12,589
|
Faire Wholesale Series F
Preferred U
|
Online wholesale
marketplace
|
4,972
|
0.7
|
5,114
|
Faire Wholesale U
|
Online wholesale
marketplace
|
4,429
|
0.6
|
4,546
|
Faire Wholesale Series G
Preferred U
|
Online wholesale
marketplace
|
3,684
|
0.6
|
3,789
|
|
|
13,085
|
1.9
|
13,449
|
Workday
|
Enterprise information
technology
|
12,450
|
1.8
|
13,548
|
Pinterest
|
Image sharing and social
media company
|
12,273
|
1.8
|
5,698
|
Databricks Series H Preferred
U
|
Data and AI platform
|
11,647
|
1.7
|
7,974
|
Databricks Series I Preferred
U
|
Data and AI platform
|
435
|
0.1
|
-
|
|
|
12,082
|
1.8
|
7,974
|
CoStar Group
|
Commercial property
information provider
|
10,776
|
1.6
|
15,817
|
Duolingo
|
Mobile learning platform
|
10,743
|
1.6
|
11,944
|
Watsco
|
Air conditioning, heating and
refrigeration
equipment distributor
|
10,611
|
1.5
|
11,076
|
Discord Series I Preferred
U
|
Communication software
|
9,448
|
1.4
|
11,006
|
Sweetgreen
|
Salad fast food chain
|
9,370
|
1.4
|
1,212
|
BillionToOne Series C
Preferred U
|
Molecular diagnostics technology
platform
|
3,984
|
0.6
|
3,438
|
BillionToOne Series D
Preferred U
|
Molecular diagnostics technology
platform
|
2,749
|
0.4
|
-
|
BillionToOne Series C-1
Preferred U
|
Molecular diagnostics technology
platform
|
2,533
|
0.4
|
-
|
|
|
9,266
|
1.4
|
3,438
|
Lyra Health Series E
Preferred U
|
Digital mental health platform for
enterprises
|
7,136
|
1.1
|
6,688
|
Lyra Health Series F
Preferred U
|
Digital mental health platform for
enterprises
|
1,664
|
0.2
|
1,591
|
|
|
8,800
|
1.3
|
8,279
|
Datadog
|
IT monitoring and analytics
platform
|
8,768
|
1.3
|
8,193
|
Solugen Series C-1 Preferred
U
|
Combines enzymes and metal
catalysts
to make chemicals
|
5,821
|
0.9
|
7,257
|
Solugen Series D Preferred
U
|
Combines enzymes and metal
catalysts
to make chemicals
|
2,827
|
0.4
|
3,487
|
|
|
8,648
|
1.3
|
10,744
|
Snyk Series F Preferred
U
|
Developer security
software
|
5,055
|
0.8
|
4,061
|
Snyk Ordinary Shares
U
|
Developer security
software
|
3,016
|
0.4
|
2,424
|
|
|
8,071
|
1.2
|
6,485
|
Affirm Class B P
|
Consumer finance
|
4,543
|
0.7
|
2,373
|
Affirm P
|
Consumer finance
|
3,477
|
0.5
|
2,116
|
|
|
8,020
|
1.2
|
4,489
|
Oddity P
|
Online cosmetics and skincare
company
|
7,072
|
1.0
|
5,648
|
Roblox
|
User generated content game
company
|
6,900
|
1.0
|
8,115
|
Epic Games U
|
Video game platform and software
developer
|
6,741
|
1.0
|
6,060
|
Wayfair
|
Online furniture and homeware
retailer
|
6,552
|
0.9
|
4,831
|
Block
|
Financial Services merchant and
mobile
payment company
|
6,127
|
0.9
|
-
|
Inspire Medical Systems
|
Medical technology
company
|
6,054
|
0.9
|
-
|
Snowflake P
|
Developer of a SaaS-based cloud data
warehousing platform
|
5,771
|
0.8
|
7,598
|
Insulet
|
Medical device company
|
5,736
|
0.8
|
-
|
Samsara
|
Connected operations cloud software
company
|
5,430
|
0.8
|
-
|
Alnylam Pharmaceuticals
|
Therapeutic gene
silencing
|
5,248
|
0.8
|
11,066
|
Human Interest Series E
Preferred U
|
Retirement benefits
platform
|
4,713
|
0.7
|
-
|
Human Interest Warrants for
Series E/E-1 U
|
Retirement benefits
platform
|
-
|
-
|
-
|
|
|
4,713
|
0.7
|
-
|
Guardant Health
|
Biotechnology company
|
4,645
|
0.7
|
-
|
Tanium Class B Common
U
|
Online security
management
|
4,548
|
0.7
|
3,814
|
Roku
|
Online media player
|
4,451
|
0.7
|
4,895
|
Nuro Series C Preferred
U
|
Self-driving vehicles for local
delivery
|
2,509
|
0.4
|
2,040
|
Nuro Series D Preferred
U
|
Self-driving vehicles for local
delivery
|
1,939
|
0.3
|
1,645
|
|
|
4,448
|
0.7
|
3,685
|
HashiCorp
|
Open source infrastructure
software
|
4,360
|
0.6
|
4,709
|
Workrise Technologies
Series E Preferred U
|
Jobs marketplace for the energy
sector
|
1,975
|
0.3
|
2,741
|
Workrise Technologies
Series D Preferred U
|
Jobs marketplace for the energy
sector
|
1,895
|
0.3
|
2,662
|
Workrise Technologies
Series D-1 Preferred U
|
Jobs marketplace for the energy
sector
|
421
|
<0.1
|
592
|
|
|
4,291
|
0.6
|
5,995
|
Chewy
|
Online pet supplies
retailer
|
4,084
|
0.6
|
6,168
|
Thumbtack Class A Common
U
|
Online directory service for local
businesses
|
2,437
|
0.4
|
810
|
Thumbtack Series I Preferred
U
|
Online directory service for local
businesses
|
1,293
|
0.2
|
1,113
|
Thumbtack Series A Preferred
U
|
Online directory service for local
businesses
|
174
|
<0.1
|
58
|
Thumbtack Series C Preferred
U
|
Online directory service for local
businesses
|
51
|
<0.1
|
17
|
Thumbtack Series B Preferred
U
|
Online directory service for local
businesses
|
12
|
<0.1
|
4
|
|
|
3,967
|
0.6
|
2,002
|
PsiQuantum Series D Preferred
U
|
Silicon photonic quantum
computing
|
3,872
|
0.6
|
3,535
|
YETI Holdings
|
Consumer products for the outdoor
and recreation markets
|
3,726
|
0.6
|
-
|
Airbnb Class B Common
P
|
Online market place for travel
accommodation
|
3,501
|
0.6
|
2,725
|
Away (JRSK) Series D
Preferred U
|
Travel and lifestyle
brand
|
1,072
|
0.2
|
1,698
|
Away (JRSK) Convertible
Promissory Note U
|
Travel and lifestyle
brand
|
1,039
|
0.2
|
1,075
|
Away (JRSK) Convertible
Promissory Note 2021 U
|
Travel and lifestyle
brand
|
1,039
|
0.2
|
1,075
|
Away (JRSK) Series Seed
Preferred U
|
Travel and lifestyle
brand
|
234
|
<0.1
|
1,165
|
|
|
3,384
|
0.6
|
5,013
|
Denali Therapeutics
|
Clinical stage neurodegeneration
company
|
3,321
|
0.5
|
5,803
|
Penumbra
|
Medical tools to treat vascular
diseases
|
3,178
|
0.5
|
5,696
|
Doximity
|
Social network and digital workflow
tools for
medical professionals
|
3,136
|
0.5
|
2,680
|
Niantic Series C Preferred
U
|
Augmented reality games
|
3,026
|
0.4
|
2,608
|
Aurora Innovation
P
|
Self-driving technology
|
1,668
|
0.2
|
368
|
Aurora Innovation Class B
Common P
|
Self-driving technology
|
1,317
|
0.2
|
785
|
|
|
2,985
|
0.4
|
1,153
|
Coursera
|
Online educational services
provider
|
2,842
|
0.4
|
4,176
|
Sprout Social
|
Social media management
firm
|
2,777
|
0.4
|
-
|
Lemonade
|
Insurance company
|
2,068
|
0.3
|
2,335
|
Recursion Pharmaceuticals
|
Drug discovery platform
|
1,891
|
0.3
|
2,111
|
Honor Technology Series D
Preferred U
|
Home care provider
|
1,158
|
0.2
|
609
|
Honor Technology Series E
Preferred U
|
Home care provider
|
502
|
0.1
|
264
|
Honor Technology Subordinated
Convertible Promissory Note U
|
Home care provider
|
198
|
<0.1
|
-
|
|
|
1,858
|
0.3
|
873
|
10X Genomics
|
Single cell sequencing
company
|
1,714
|
0.3
|
4,361
|
Capsule Series 1-D Preferred
U
|
Digital pharmacy
|
824
|
0.1
|
1,305
|
Capsule Series E Preferred
U
|
Digital pharmacy
|
509
|
0.1
|
807
|
|
|
1,333
|
0.2
|
2,112
|
Sana Biotechnology
|
Gene editing technology
|
1,239
|
0.2
|
929
|
Rivian Automotive
|
Electric vehicle
manufacturer
|
1,078
|
0.2
|
1,560
|
Ginkgo Bioworks P
|
Bioengineering company developing
micro organisms that produce various proteins
|
930
|
0.1
|
2,946
|
Blockstream Series B-1
Preferred U
|
Bitcoin and digital asset
infrastructure
|
163
|
<0.1
|
1,140
|
Indigo Agriculture Class A
Common U
|
Agricultural technology
company
|
130
|
<0.1
|
2,375
|
Abiomed CVR U
|
Manufacturer of heart
pumps
|
-
|
-
|
-
|
Total investments
|
|
678,234
|
99.3
|
|
Net liquid
assets
|
|
4,970
|
0.7
|
|
Total assets*
|
|
683,204
|
100.0
|
|
|
Listed
equities
%
|
Private
company
investments #
%
|
Net liquid
assets
%
|
Total
assets *
%
|
31 May 2024
|
65.2
|
34.1
|
0.7
|
100.0
|
31 May 2023
|
65.0
|
34.5
|
0.5
|
100.0
|
* Total
assets less current liabilities, before deduction of borrowings.
See Glossary of terms and alternative performance measures at the
end of this announcement.
† See
Glossary of terms and alternative performance measures at the end
of this announcement.
# Includes
holdings in ordinary shares, preference shares and convertible
promissory notes.
U Denotes private
company investment.
P Denotes listed
investment previously held in the portfolio as a private company
investment.
Past performance is not a guide to
future performance.
Income statement
For the year ended 31 May
|
Notes
|
2024
Revenue
£'000
|
2024
Capital
£'000
|
2024
Total
£'000
|
2023
Revenue
£'000
|
2023
Capital
£'000
|
2023
Total
£'000
|
Gains/(losses) on
investments
|
|
-
|
95,288
|
95,288
|
-
|
(10,169)
|
(10,169)
|
Currency gains/(losses)
|
|
-
|
878
|
878
|
-
|
(700)
|
(700)
|
Income
|
2
|
603
|
-
|
603
|
850
|
-
|
850
|
Investment management fee
|
3
|
(3,581)
|
-
|
(3,581)
|
(3,345)
|
-
|
(3,345)
|
Other administrative
expenses
|
|
(726)
|
-
|
(726)
|
(670)
|
-
|
(670)
|
Net return before finance costs
and taxation
|
|
(3,704)
|
96,166
|
92,462
|
(3,165)
|
(10,869)
|
(14,034)
|
Finance costs of
borrowings
|
8
|
(2,528)
|
-
|
(2,528)
|
(1,482)
|
-
|
(1,482)
|
Net return before
taxation
|
|
(6,232)
|
96,166
|
89,934
|
(4,647)
|
(10,869)
|
(15,516)
|
Tax on ordinary
activities
|
|
(50)
|
-
|
(50)
|
(71)
|
-
|
(71)
|
Net return after taxation
|
|
(6,282)
|
96,166
|
89,884
|
(4,718)
|
(10,869)
|
(15,587)
|
Net return per ordinary
share
|
4
|
(2.07p)
|
31.73p
|
29.66p
|
(1.55p)
|
(3.56p)
|
(5.11p)
|
The total column of this statement
is the profit and loss account of the Company. The supplementary
revenue and capital return columns are prepared under guidance
published by the Association of Investment Companies.
All revenue and capital items in
this statement derive from continuing operations.
A Statement of Comprehensive Income
is not required as all gains and losses of the Company have been
reflected in the above statement.
The accompanying notes below are an
integral part of the Financial Statements.
Balance sheet
As at 31 May
|
Notes
|
2024
£'000
|
2024
£'000
|
2023
£'000
|
2023
£'000
|
Fixed assets
|
|
|
|
|
|
Investments held at fair value
through profit or loss
|
6
|
|
678,234
|
|
605,908
|
Current assets
|
|
|
|
|
|
Debtors
|
|
605
|
|
657
|
|
Cash and cash equivalents
|
|
6,620
|
|
3,440
|
|
|
|
7,225
|
|
4,097
|
|
Creditors
|
|
|
|
|
|
Amounts falling due within one
year
|
8
|
(41,526)
|
|
(41,406)
|
|
Net current liabilities
|
|
|
(34,301)
|
|
(37,309)
|
Net assets
|
|
|
643,933
|
|
568,599
|
Capital and reserves
|
|
|
|
|
|
Share capital
|
|
|
3,073
|
|
3,073
|
Share premium account
|
|
|
250,827
|
|
250,827
|
Special distributable
reserve
|
|
|
168,942
|
|
168,942
|
Capital reserve
|
|
|
247,547
|
|
165,931
|
Revenue reserve
|
|
|
(26,456)
|
|
(20,174)
|
Total shareholders' funds
|
|
|
643,933
|
|
568,599
|
Net asset value per ordinary
share*
|
|
|
216.65p
|
|
186.33p
|
Ordinary shares in issue
|
10
|
|
297,228,700
|
|
305,153,700
|
* Net asset
value per ordinary share after deducting borrowings at book value.
See Glossary of terms and alternative performance measures at the
end of this announcement.
The accompanying notes below are an
integral part of the Financial Statements.
Statement of changes in equity
For the year ended 31 May
2024
|
Notes
|
Share
capital
£'000
|
Share
premium
account
£'000
|
Special
distributable reserve
£'000
|
Capital
reserve*
£'000
|
Revenue
reserve
£'000
|
Shareholders'
funds
£'000
|
Shareholders' funds at 1 June
2023
|
|
3,073
|
250,827
|
168,942
|
165,931
|
(20,174)
|
568,599
|
Ordinary shares bought back into
treasury
|
10
|
-
|
-
|
-
|
(14,550)
|
-
|
(14,550)
|
Net return after taxation
|
|
-
|
-
|
-
|
96,166
|
(6,282)
|
89,884
|
Shareholders' funds at 31 May
2024
|
|
3,073
|
250,827
|
168,942
|
247,547
|
(26,456)
|
643,933
|
For the year ended 31 May
2023
|
Notes
|
Share
capital
£'000
|
Share
premium
account
£'000
|
Special
reserve
£'000
|
Capital
reserve*
£'000
|
Revenue
reserve
£'000
|
Shareholders'
funds
£'000
|
Shareholders' funds at 1 June
2022
|
|
3,073
|
250,827
|
168,942
|
176,800
|
(15,456)
|
584,186
|
Ordinary shares bought back into
treasury
|
10
|
-
|
-
|
-
|
-
|
-
|
-
|
Net return after taxation
|
|
-
|
-
|
-
|
(10,869)
|
(4,718)
|
(15,587)
|
Shareholders' funds at 31 May
2023
|
|
3,073
|
250,827
|
168,942
|
165,931
|
(20,174)
|
568,599
|
* The
capital reserve includes investment holding gains on fixed asset
investments of £144,945,000 (2023 - gains of
£26,558,000).
The accompanying notes below are an
integral part of the Financial Statements.
Cash flow statement
For the year ended 31 May
|
Notes
|
2024
£'000
|
2024
£'000
|
2023
£'000
|
2023
£'000
|
Cash flows from operating activities
|
|
|
|
|
|
Net return before
taxation
|
|
|
89,934
|
|
(15,516)
|
Adjustments to reconcile company profit before tax
to net cash flow from operating activities
|
|
|
|
|
|
Net (gains)/losses on
investments
|
|
|
(95,288)
|
|
10,169
|
Currency (gains)/losses
|
|
|
(878)
|
|
700
|
Finance costs of
borrowings
|
|
|
2,528
|
|
1,482
|
Other capital movements
|
|
|
|
|
|
Overseas withholding tax
incurred
|
|
|
(50)
|
|
(71)
|
Changes in debtors
|
|
|
51
|
|
(298)
|
Changes in creditors
|
|
|
191
|
|
(10)
|
Cash from
operations*
|
|
|
(3,512)
|
|
(3,544)
|
Finance costs paid
|
|
|
(2,308)
|
|
(1,481)
|
Net cash outflow from operating
activities
|
|
|
(5,820)
|
|
(5,025)
|
Cash
flows from investing activities
|
|
|
|
|
|
Acquisitions of
investments
|
|
(95,852)
|
|
(63,894)
|
|
Disposals of investments
|
|
118,814
|
|
69,383
|
|
Net cash inflow from investing
activities
|
|
|
22,962
|
|
5,489
|
Cash flows from financing
activities
|
|
|
|
|
|
Ordinary shares bought back into
treasury
and stamp duty thereon
|
10
|
(13,769)
|
|
-
|
|
Bank loans drawn down
|
|
20,577
|
|
-
|
|
Bank loans repaid
|
|
(20,577)
|
|
-
|
|
Net cash outflow from financing
activities
|
|
|
(13,769)
|
|
-
|
Increase in cash and cash
equivalents
|
|
|
3,373
|
|
464
|
Exchange movements
|
|
|
(193)
|
|
(31)
|
Cash and cash equivalents at 1
June
|
|
|
3,440
|
|
3,007
|
Cash and cash equivalents at 31
May
|
|
|
6,620
|
|
3,440
|
* Cash from operations includes
dividends received of £331,000 (2023 - £472,000) and interest
received of £35,000 (2023 - £154,000).
The accompanying notes below are an
integral part of the Financial Statements.
Notes to the Financial Statements
1. Principal accounting
policies
The Financial Statements for the
year to 31 May 2024 have been prepared in accordance with FRS 102
'The Financial Reporting Standard applicable in the UK and Republic
of Ireland' and on the basis of the accounting policies set out
below which are unchanged from the prior year and have been applied
consistently.
2. Income
|
2024
£'000
|
2023
£'000
|
Income from investments
|
|
|
Overseas dividends
|
536
|
472
|
Overseas interest
|
32
|
224
|
|
568
|
696
|
Other income
|
|
|
Deposit interest
|
35
|
154
|
Total income
|
603
|
850
|
3. Investment management
fee
Baillie Gifford & Co Limited, a
wholly owned subsidiary of Baillie Gifford & Co, has been
appointed as the Company's Alternative Investment Fund Manager
('AIFM') and Company Secretaries. Baillie Gifford & Co Limited
has delegated portfolio management services to Baillie Gifford
& Co. Dealing activity and transaction reporting have been
further sub-delegated to Baillie Gifford Overseas Limited and
Baillie Gifford Asia (Hong Kong) Limited.
The annual management fee is 0.70%
on the first £100 million of net assets, 0.55% on the next £900
million of net assets and 0.50% on the remaining net assets.
Management fees are calculated and payable quarterly. The Board is
of the view that calculating the fee with reference to performance
would be unlikely to exert a positive influence on
performance.
4. Net return per ordinary
share
|
2024
Revenue
|
2024
Capital
|
2024
Total
|
2023
Revenue
|
2023
Capital
|
2023
Total
|
Net return after taxation
|
(2.07p)
|
31.73p
|
29.66p
|
(1.55p)
|
(3.56p)
|
(5.11p)
|
Revenue return per ordinary share
is based on the net revenue loss after taxation of £6,282,000 (2023
- net revenue loss after taxation of £4,718,000) and on 303,075,968
(2023 - 305,153,700) ordinary shares, being the weighted average
number of ordinary shares in issue (excluding treasury shares)
during each period.
Capital return per ordinary share
is based on the net capital profit for the financial period of
£96,166,000 (2023 - net capital loss of £10,869,000) and on
303,075,968 (2023 - 305,153,700) ordinary shares, being the
weighted average number of ordinary shares in issue (excluding
treasury shares) during each period.
Total return per ordinary share is
based on the total profit for the financial period of £89,884,000
(2023 - total loss of £15,587,000) and on 303,075,968 (2023 -
305,153,700) ordinary shares, being the weighted average number of
ordinary shares in issue (excluding treasury shares) during each
period.
There are no dilutive or
potentially dilutive shares in issue.
5. Ordinary
dividends
There are no dividends paid or
proposed in respect of the financial year. There is no investment
income available for distribution by way of dividend for the year
to 31 May 2024 due to the revenue loss of £6,282,000 in the year
(2023 - revenue loss of £4,718,000).
6. Fair value
hierarchy
As at 31 May 2024
|
Level 1
£'000
|
Level 2
£'000
|
Level 3
£'000
|
Total
£'000
|
Listed equities
|
447,044
|
-
|
-
|
447,044
|
Unlisted ordinary shares
|
-
|
-
|
38,928
|
38,928
|
Unlisted preference
shares*
|
-
|
-
|
189,986
|
189,986
|
Unlisted convertible promissory
note
|
-
|
-
|
2,276
|
2,276
|
Unlisted CVR †
|
-
|
-
|
-
|
-
|
Total financial asset
investments
|
447,044
|
-
|
231,190
|
678,234
|
As at 31 May 2023
|
Level 1
£'000
|
Level 2
£'000
|
Level 3
£'000
|
Total
£'000
|
Listed equities
|
396,272
|
-
|
-
|
396,272
|
Unlisted ordinary shares
|
-
|
-
|
37,307
|
37,307
|
Unlisted preference
shares*
|
-
|
-
|
168,162
|
168,162
|
Unlisted convertible promissory
note
|
-
|
-
|
4,167
|
4,167
|
Unlisted CVR †
|
-
|
-
|
-
|
-
|
Total financial asset
investments
|
396,272
|
-
|
209,636
|
605,908
|
*
The investments in preference shares are not
classified as equity holdings as they include liquidation
preference rights that determine the repayment (or multiple
thereof) of the original investment in the event of a liquidation
event such as a take-over.
†
The Abiomed CVR (see 'Contingent value rights'
below for details) had a fair value of nil at 31 May 2024 and 31
May 2023.
During the year to 31 May 2024
investments with a book cost of £5,725,000 (31 May 2023 - no
investments) were transferred from Level 3 to Level 1 on becoming
listed. Investments in securities are financial assets held at fair
value through profit or loss. In accordance with FRS 102, the
tables above provide an analysis of these investments based on the
fair value hierarchy described below, which reflects the
reliability and significance of the information used to measure
their fair value.
Fair value hierarchy
The fair value hierarchy used to
analyse the fair values of financial assets is described below. The
levels are determined by the lowest (that is the least reliable or
least independently observable) level of input that is significant
to the fair value measurement for the individual investment in its
entirety as follows:
Level 1 - using unadjusted quoted
prices for identical instruments in an active market;
Level 2 - using inputs, other than
quoted prices included within Level 1, that are directly or
indirectly observable (based on market data); and
Level 3 - using inputs that are
unobservable (for which market data is unavailable).
The valuation techniques used by
the Company are explained in the accounting policies on pages 95
and 96 of the Annual Report and Financial Statements. A sensitivity
analysis by valuation technique of the unlisted securities is given
on pages 106 to 109 of the Annual Report and Financial
Statements.
7. Transaction
costs
Transaction costs of £21,000 (2023
- £12,000) and £28,000 (2023 - £14,0000) were suffered on purchases
and sales respectively.
8. Borrowing
facilities
The US$25 million five-year
revolving credit facility with ING Bank N.V., London Branch matured
on 31 July 2023 and was refinanced with a new unsecured US$25
million three-year revolving credit facility from ING Bank N.V.,
London Branch on 26 July 2023. At 31 May 2024 there were drawings
of US$25 million at an interest rate of 7.01% (2023 - US$25 million
at an interest rate of 6.87%). The US$25 million three-year fixed
rate facility with ING Bank N.V., London Branch matured on 23
October 2023 and was refinanced with a new unsecured US$25 million
three-year revolving credit facility, from The Royal Bank of
Scotland International Limited, on 18 October 2023. At 31 May 2024
there were drawings of US$25 million at an interest rate of 6.61%
(2023 - US$25 million at an interest rate of 1.90%).
The main covenants relating to the
loans are that borrowings should not exceed 30% of the Company's
adjusted net asset value or adjusted portfolio value and the
Company's minimum adjusted net asset value or adjusted portfolio
value shall be £140 million. The adjusted net asset value and
adjusted portfolio value calculations include the deduction of 100%
of the value of any unlisted securities. There were no breaches in
the loan covenants during the year to 31 May 2024 (31 May 2023 -
none).
9. Analysis of change in net
debt
|
At 31 May
2023
£'000
|
Cash flows
£'000
|
Exchange
movement
£'000
|
At 31 May
2024
£'00
|
Cash and cash equivalents
|
3,440
|
3,373
|
(193)
|
6,620
|
Loans due within one year
|
(40,342)
|
-
|
1,071
|
(39,271)
|
|
(36,902)
|
3,373
|
878
|
(32,651)
|
10. Share
capital
|
2024
Number
|
2024
£'000
|
2023
Number
|
2023
£'000
|
Allotted, called up and fully paid
ordinary shares of 1p each
|
297,228,700
|
2,972
|
305,153,700
|
3,051
|
Treasury shares of 1p
each
|
10,131,300
|
101
|
2,206,300
|
22
|
|
307,360,000
|
3,073
|
307,360,000
|
3,073
|
In the year to 31 May 2024, the
Company issued no shares (2023 - nil).
Over the period from 1 June 2024 to
16 August 2024 the Company has issued no shares.
The Company's authority to buy back
shares up to a maximum of 14.99% of the Company's issued share
capital was renewed at the Annual General Meeting held on 18
September 2023. In the year to 31 May 2024 7,925,000 shares with a
nominal value of £79,250 were bought back at a total cost of
£14,550,000 and held in treasury (2023 - nil). At 31 May 2024 the
Company had authority to buy back 37,817,539 ordinary
shares.
Over the period from 1 June 2024 to
16 August 2024 the Company bought back 1,950,000 shares.
11. The financial
information set out above does not constitute the Company's
statutory accounts for the year ended 31 May 2024 or the year ended
31 May 2023 but is derived from those accounts. Statutory accounts
for the period to 31 May 2023 have been delivered to the Registrar
of Companies, and those for the year to 31 May 2024 will be
delivered in due course. The auditor has reported on those
accounts; the reports were (i) unqualified, (ii) did not include a
reference to any matters to which the auditor drew attention by way
of emphasis without qualifying their report and (iii) did not
contain a statement under section 498 (2) or (3) of the Companies
Act 2006.
12. Transactions with
related parties and the Managers and Secretaries
The Directors' fees and
shareholdings are detailed in the Directors' remuneration report on
pages 76 to 79 of the Annual Report and Financial Statements. No
Director has a contract of service with the Company. During the
period no Director was interested in any contract or other matter
requiring disclosure under section 412 of the Companies Act
2006.
Details of the management fee
arrangements are included in note 3 above.
13. The Annual Report and Financial Statements will be available
on the Company website
bgusgrowthtrust.com‡ on or
around 28 August 2024.
‡ Neither
the contents of the Company website nor the contents of any website
accessible from hyperlinks on the Company website (or any other
website) is incorporated into, or forms part of, this
announcement.
Glossary of terms and alternative performance measures
('APM')
An alternative performance measure
('APM') is a financial measure of historical or future financial
performance, financial position, or cash flows, other than a
financial measure defined or specified in the applicable financial
reporting framework. The APMs noted below are commonly used
measures within the investment trust industry and serve to improve
comparability between investment trusts.
Total assets
This is the Company's definition of
Adjusted Total Assets, being the total value of all assets held
less all liabilities (other than liabilities in the form of
borrowings).
Shareholders' funds and net asset value
Shareholders' funds is the value of
all assets held less all liabilities, with borrowings deducted at
book cost. Net asset value ('NAV') is the value of all assets held
less all liabilities, with borrowings deducted at either fair value
or book value as described below. Per share amounts are calculated
by dividing the relevant figure by the number of ordinary shares in
issue.
Borrowings at book value
Borrowings are valued at adjusted
net issue proceeds. The value of the borrowings at book is set out
on page 111 of the Annual Report and Financial
Statements.
Borrowings at fair value (APM)
Borrowings are valued at an estimate
of their market worth. The value of the borrowings at fair is set
out on page 111 of the Annual Report and Financial
Statements.
Net
asset value (reconciliation of NAV at book value to NAV at fair
value)
|
2024
|
2023
|
Net asset value per ordinary share
(borrowings at book value)
|
216.65p
|
186.33p
|
Shareholders' funds (borrowings at
book value)
|
£643,933,000
|
£568,599,000
|
Add: book value of
borrowings
|
£39,271,000
|
£40,342,000
|
Less: fair value of
borrowings
|
(£39,271,000)
|
(£39,904,000)
|
Net
asset value (borrowings at fair value)
|
£643,933,000
|
£569,037,000
|
Number of shares in issue
|
297,228,700
|
305,153,700
|
Net
asset value per ordinary share (borrowings at fair
value)
|
216.65p
|
186.48p
|
Net liquid assets
Net liquid assets comprise current
assets less current liabilities (excluding borrowings).
Discount/premium (APM)
As stock markets and share prices
vary, an investment trust's share price is rarely the same as its
NAV. When the share price is lower than the NAV per share it is
said to be trading at a discount. The size of the discount is
calculated by subtracting the share price from the NAV per share
and is usually expressed as a percentage of the NAV per share. If
the share price is higher than the NAV per share, it is said to be
trading at a premium.
|
|
2024
|
2023
|
Net asset value per ordinary
share
(after deducting borrowings at fair value)
|
a
|
216.65p
|
186.48p
|
Share price
|
b
|
192.40p
|
144.80p
|
Discount (borrowings at fair
value)
|
(b-a) ÷
a
|
11.2%
|
22.4%
|
|
|
2024
|
2023
|
Net asset value per ordinary
share
(after deducting borrowings at book value)
|
a
|
216.65p
|
186.33p
|
Share price
|
b
|
192.40p
|
144.80p
|
Discount (borrowings at book
value)
|
(b-a) ÷
a
|
11.2%
|
22.3%
|
Total return (APM)
The total return is the return to
shareholders after reinvesting any dividend on the date that the
share price goes ex-dividend. The Company does not pay a dividend,
therefore, the one year and since inception total returns for the
share price and NAV per share at book and fair value are the same
as the percentage movements in the share price and NAV per share at
book and fair value as detailed above.
Ongoing charges (APM)
The total recurring expenses
(excluding the Company's cost of dealing in investments and
borrowing costs) incurred by the Company as a percentage of the
average net asset value (with debt at fair value).
|
|
31 May
2024
£'000
|
31 May
2023
£'000
|
Investment management fee
|
|
3,581
|
3,345
|
Other administrative
expenses
|
|
726
|
670
|
Total expenses
|
a
|
4,307
|
4,015
|
Average net asset value
|
b
|
616,958
|
578,722
|
Ongoing charges (a
÷ b expressed as a
percentage)
|
|
0.70%
|
0.69%
|
Turnover (APM)
Annual turnover is a measure of
portfolio change or trading activity in a portfolio. Turnover is
calculated as the minimum of purchases and sales in a month,
divided by the average market value of the portfolio, summed to get
rolling 12 month turnover data.
Gearing (APM)
At its simplest, gearing is
borrowing. Just like any other public company, an investment trust
can borrow money to invest in additional investments for its
portfolio. The effect of the borrowing on the shareholders' assets
is called 'gearing'. If the Company's assets grow, the
shareholders' assets grow proportionately more because the debt
remains the same. But if the value of the Company's assets falls,
the situation is reversed. Gearing can therefore enhance
performance in rising markets but can adversely impact performance
in falling markets.
Gearing is the Company's borrowings
at book value less cash and cash equivalents (including any
outstanding trade settlements) expressed as a percentage of
shareholders' funds.
|
31 May
2024
£'000
|
31 May
2023
£'000
|
Borrowings (at book cost)
|
£39,271
|
£40,342
|
Less: cash and cash
equivalents
|
(£6,620)
|
(£3,440)
|
Adjusted borrowings (a)
|
£32,651
|
£36,902
|
Shareholders' funds (b)
|
£643,933
|
£568,599
|
Gearing: (a) as a percentage of
(b)
|
5%
|
6%
|
Gross gearing is the Company's
borrowings expressed as a percentage of shareholders'
funds.
|
31 May
2024
£'000
|
31 May
2023
£'000
|
Borrowings (at book cost)
(a)
|
£39,271
|
£40,342
|
Shareholders' funds (b)
|
£643,933
|
£568,599
|
Gross gearing: (a) as a percentage
of (b)
|
6%
|
7%
|
Leverage (APM)
For the purposes of the Alternative
Investment Fund Managers Regulations, leverage is any method which
increases the Company's exposure, including the borrowing of cash
and the use of derivatives. It is expressed as a ratio between the
Company's exposure and its net asset value and can be calculated on
a gross and a commitment method. Under the gross method, exposure
represents the sum of the Company's positions after the deduction
of sterling cash balances, without taking into account any hedging
and netting arrangements. Under the commitment method, exposure is
calculated without the deduction of sterling cash balances and
after certain hedging and netting positions are offset against each
other.
Active share (APM)
Active share, a measure of how
actively a portfolio is managed, is the percentage of the portfolio
that differs from its comparative index. It is calculated by
deducting from 100 the percentage of the portfolio that overlaps
with the comparative index. An active share of 100 indicates no
overlap with the index and an active share of zero indicates a
portfolio that tracks the index.
Treasury shares
The Company has the authority to
make market purchases of its ordinary shares for retention as
treasury shares for future reissue, resale, transfer, or for
cancellation. Treasury shares do not receive distributions and the
Company is not entitled to exercise the voting rights attaching to
them.
Private (unlisted) company
An unlisted or private company means
a company whose shares are not available to the general public for
trading and are not listed on a stock exchange.
Contingent value rights
'CVR' after an instrument name
indicates a security, usually arising from a corporate action such
as a takeover or merger, which represents a right to receive
potential future value, should the continuing company achieve
certain milestones. The Abiomed CVR arose on Johnson &
Johnson's takeover of Abiomed. The milestones relate to the
performance of the technologies acquired through the takeover. Any
value attributed to this holding reflects both the amount of the
future value potentially receivable and the probability of the
milestones being met within the time frames in the CVR
agreement.
Sustainable Finance Disclosure Regulation
('SFDR')
The EU Sustainable Finance
Disclosure Regulation ('SFDR') does not have a direct impact in the
UK due to Brexit. However, it applies to third-country products
marketed in the EU. As Baillie Gifford US Growth is marketed in the
EU by the AIFM, Baillie Gifford & Co Limited, via the National
Private Placement Regime ('NPPR') the following disclosures have
been provided to comply with the high-level requirements of
SFDR.
The AIFM has adopted Baillie Gifford
& Co's stewardship principles and guidelines as its policy on
integration of sustainability risks in investment
decisions.
Baillie Gifford & Co believes
that a company cannot be financially sustainable in the long run if
its approach to business is fundamentally out of line with changing
societal expectations. It defines 'sustainability' as a
deliberately broad concept which encapsulates a company's purpose,
values, business model, culture, and operating
practices.
Baillie Gifford & Co's approach
to investment is based on identifying and holding high quality
growth businesses that enjoy sustainable competitive advantages in
their marketplace. To do this it looks beyond current financial
performance, undertaking proprietary research to build up an
in-depth knowledge of an individual company and a view on its
long-term prospects. This includes the consideration of
sustainability factors (environmental, social and/or governance
matters) which it believes will positively or negatively influence
the financial returns of an investment. The likely impact on the
return of the portfolio from a potential or actual material decline
in the value of investment due to the occurrence of an
environmental, social or governance event or condition will vary
and will depend on several factors including but not limited to the
type, extent, complexity and duration of an event or condition,
prevailing market conditions and existence of any mitigating
factors.
Whilst consideration is given to
sustainability matters, there are no restrictions on the investment
universe of the Company, unless otherwise stated within in its
investment objective & policy. Baillie Gifford & Co can
invest in any companies it believes could create beneficial
long-term returns for investors. However, this might result in
investments being made in companies that ultimately cause a
negative outcome for the environment or society.
More detail on the Manager's
approach to sustainability can be found in the stewardship
principles and guidelines document, available publicly on the
Baillie Gifford website bailliegifford.com‡.
The underlying investments do not
take into account the EU criteria for environmentally sustainable
economic activities established under the EU Taxonomy
Regulation.
None of the views expressed in this
document should be construed as advice to buy or sell a particular
investment.
‡ Neither
the contents of the Managers' website nor the contents of any
website accessible from hyperlinks on the Managers' website (or any
other website) is incorporated into, or forms part of, this
announcement.
Third party data provider disclaimer
No third party data provider
('Provider') makes any warranty, express or implied, as to the
accuracy, completeness or timeliness of the data contained herewith
nor as to the results to be obtained by recipients of the
data.
No Provider shall in any way be
liable to any recipient of the data for any inaccuracies, errors or
omissions in the index data included in this document, regardless
of cause, or for any damages (whether direct or indirect) resulting
therefrom. No Provider has any obligation to update, modify or
amend the data or to otherwise notify a recipient thereof in the
event that any matter stated herein changes or subsequently becomes
inaccurate.
Without limiting the foregoing, no
Provider shall have any liability whatsoever to you, whether in
contract (including under an indemnity), in tort (including
negligence), under a warranty, under statute or otherwise, in
respect of any loss or damage suffered by you as a result of or in
connection with any opinions, recommendations, forecasts,
judgements or any other conclusions, or any course of action
determined, by you or any third party, whether or not based on the
content, information or materials contained herein.
S&P Index data
The S&P 500 Index ('Index') is a
product of S&P Dow Jones Indices LLC, a division of S&P
Global, or its affiliates ('SPDJI'). Standard & Poor's® and
S&P® are registered trademarks of Standard & Poor's
Financial Services LLC, a division of S&P Global ('S&P');
Dow Jones® is a registered trademark of Dow Jones Trademark
Holdings LLC ('Dow Jones'). Neither S&P Dow Jones Indices LLC,
Dow Jones Trademark Holdings LLC, their affiliates nor their third
party licensors make any representation or warranty, express or
implied, as to the ability of any index to accurately represent the
asset class or market sector that it purports to represent and
neither S&P Dow Jones Indices LLC, Dow Jones Trademark Holdings
LLC, their affiliates nor their third party licensors shall have
any liability for any errors, omissions, or interruptions of any
index or the data included therein.
FTSE Index Data
London Stock Exchange Group plc and
its group undertakings (collectively, the 'LSE Group'). © LSE Group
2024. FTSE Russell is a trading name of certain of the LSE Group
companies. 'FTSE®' 'Russell®', 'FTSE Russell®', is/are a trade
mark(s) of the relevant LSE Group companies and is/are used by any
other LSE Group company under license. All rights in the FTSE
Russell indexes or data vest in the relevant LSE Group company
which owns the index or the data. Neither LSE Group nor its
licensors accept any liability for any errors or omissions in the
indexes or data and no party may rely on any indexes or data
contained in this communication. No further distribution of data
from the LSE Group is permitted without the relevant LSE Group
company's express written consent. The LSE Group does not promote,
sponsor or endorse the content of this communication.
- ends
-